News - Page 183 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Field Trip Health Ltd. Announces Opening of Psychedelic-Enhanced Therapy Center in Houston; Locations of Next 5 Field Trip Health Centers

Field Trip Health Ltd. Announces Opening of Psychedelic-Enhanced Therapy Center in Houston; Locations of Next 5 Field Trip Health Centers

Post published:May 4, 2021
Post category:Press Release

Read more about the article Psyched Wellness Signs Supply Agreement for Amanita Muscaria

Psyched Wellness Signs Supply Agreement for Amanita Muscaria

Post published:May 4, 2021
Post category:Press Release

Read more about the article Small Pharma Inc. to Commence Trading on the TSX Venture Exchange on May 6, 2021

Small Pharma Inc. to Commence Trading on the TSX Venture Exchange on May 6, 2021

Post published:May 4, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Partners with Fluence for Psychotherapy Design

Tryp Therapeutics Partners with Fluence for Psychotherapy Design

Post published:May 3, 2021
Post category:Press Release

Read more about the article Mydecine Reports Full Year 2020 Financial Results and Provides Business Update

Mydecine Reports Full Year 2020 Financial Results and Provides Business Update

Post published:May 3, 2021
Post category:Press Release

Read more about the article Champignon Brands Changes Name to Braxia Scientific to Reflect the Integration of Ketamine and Psychedelic Clinics and its Research and Development Priorities

Champignon Brands Changes Name to Braxia Scientific to Reflect the Integration of Ketamine and Psychedelic Clinics and its Research and Development Priorities

Post published:May 3, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: MindMed Uplists to Nasdaq; Cybin Targets Alcoholism; COMPASS Announces $144m Offering

Psychedelic Bulletin: MindMed Uplists to Nasdaq; Cybin Targets Alcoholism; COMPASS Announces $144m Offering

Post published:April 30, 2021
Post category:Psychedelic Bulletin

Read more about the article COMPASS Pathways announces pricing of public offering

COMPASS Pathways announces pricing of public offering

Post published:April 30, 2021
Post category:Press Release

Read more about the article Bexson Biomedical Granted USPTO Patent On Proprietary Ketamine Formulation

Bexson Biomedical Granted USPTO Patent On Proprietary Ketamine Formulation

Post published:April 29, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Announces Q2 2021 Financial Results

Tryp Therapeutics Announces Q2 2021 Financial Results

Post published:April 29, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.